• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1999 Fiscal Year Final Research Report Summary

Central muscarinic mechanisms of bladder overactivity associated with Alzheimer type senile dementia.

Research Project

Project/Area Number 10470334
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Urology
Research InstitutionKanazawa University

Principal Investigator

YOKOYAMA Osamu  University Hospital, Kanazawa University Assistant Professor., 医学部・附属病院, 講師 (90242552)

Co-Investigator(Kenkyū-buntansha) KOMATU Kazuto  University Hospital, Kanazawa University Assistant Professor., 医学部・附属病院, 助手 (80291368)
KO Eitetu  University Hospital, Kanazawa University Assistant Professor., 医学部・附属病院, 助手 (90283134)
NAMIKI Mikio  School of Medicine, Kanazawa University Professor, 医学部, 教授 (70155985)
Project Period (FY) 1998 – 1999
KeywordsAlzheimer dementia / neurogenic bladder / bladder overactivity / muscarine / brain / bladder / urinary incontinence / ibotenic acid
Research Abstract

OBJECTS : To investigate the mechanisms of neurogenic bladder overactivity in Alzheimer type senile dementia in a conscious rat model.
METHODS : Male Wistar rats were placed in a stereotaxic apparatus, and subjected to bilateral lesion of the basal forebrain by means of ibotenic acid (IA) injection (7.5 μg/rat on each side)(BF rats). Phosphate buffered saline (PBS) was injected to control rats (sham operated rats ; SO rats). Cystometrograms (CMG) were obtained 7 to 10 days after IA/PBS injection. After CMG recording, choline-acetyltransferase (CAT) activities in the frontal cortices were assayed to assess the damage to cholinergic neuronal projections from basal forebrain to frontal cortices. The influences of intracerebroventricular administration of Oxotremorine M, muscarinic receptor agonist, or pirenzepine, M1 muscarinic receptor antagonist were investigated in conscious BF or SO rats. Antagonized effects of pirenzepine were also examined in BF rats. The effects of oxotremorine M or … More pirensepine directly injected into the PMC (pontine micturition center) were examined under urethane anesthesia.
RESULTS : Bladder capacity become significantly smaller than before IA injection. Seven to 10 days after IA injection, bladder capacity was approximately 43% of SO rats. CAT activity in the frontal cortices was reduced in BF rats. Oxotremorine M increased bladder capacity in BF rats, while decreased in SO rats. Pirensepine significantly increased bladder capacity both in BF and SO rats, and antagonised the effect of oxotremorine M. Direct injection of oxotremorine M into the PMC decreased bladder capacity in BF and SO rats, while injection of pirensepine had no effects on CMG.
CONCLUSIONS : These results indicate that M1 muscarinic system in the cerebral cortex has inhibitory influence to micturition reflex pathway. Down-regulation of this inhibitory mechanism plays an important role on overactive bladder in Alzheimer type dementia. M2 muscarinic system in the brainstem is likely to have excitatory influence on micturition reflex pathway. Less

  • Research Products

    (13 results)

All Other

All Publications (13 results)

  • [Publications] Yokoyama, O, Kamatsu K et al.: "Change in bladder contractility associated with bladder overactivity in rats with cerebral infarction"J. Urol. 159. 577-580 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yokoyama O, Ishiura Y, et al.: "Effects of MK-801 on bladder overactivity in rats with cerebral infarction"J. Urol. 159. 571-576 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yokoyama O, Yoshiyama M, et al.: "Glutamatergic and dopaminergic contributions to rat bladder hyperactivity after cerebral artery occlusion"Am. J. Physiol. 276. R935-R942 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ishimura Y, Yokoyama O, et al.: "Central muscarinic mechanisms regulating voiding in rats"Neurourol Urodyn. 18. 351-352 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakamura Y, Yokoyama O, et al.: "Effects of nifedipine on bladder overactivity in rats with cerebral infarction"J. Urol. 162. 1502-1507 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakada Y, Yokoyama O, et al.: "Effects of aniracetam on bladder overactivity in rats with cerebral infarction"J. Pharmacol. Exp Ther. (in press). (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 横山 修: "尿失禁に対する経膣的手術のコツ.臨床泌尿器科のコツと落とし穴"中山書店. 165 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 児玉浩一、横山 修: "脳梗塞ラットモデルを用いた研究法。神経泌尿器科学研究法"日本医学館. 172 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yokoyama O, Komatsu K, et al: "Change in bladder contractility associated with bladder overactivity in rats with cerebral infarction"J. Urol. 159. 577-580 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yokoyama O, Ishiura Y, et al: "Effects of MK-801 on bladder overactivity in rats with cerebral infarction"J. Urol. 159. 571-576 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yokoyama O, Yoshiyama M, et al: "Glutamatergic and dopaminergic contributions to rat bladder hyperactivity after cerebral artery ocelasion"Am J. Physiol. 276. R935-R942 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ishiura Y, Yokoyama O, Namiki M, et al: "Central muscarinic mechanisms regulating voiding in rats"Neurourol Urodyn. 18. 351-352 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakamura Y, Yokoyama O, et al: "Effeits of nitedipine on bladder overactivity in rats with cerebral infarction."J Urol. 162. 1502-1507 (1999)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2001-10-23  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi